Genzyme Belgium Genzyme Corporate Search Contact us
HealthcarePatients & FamiliesPractical Info
A disease with many faces
 
Healthcare Professionals
About Lysosomal Storage Disease
Gaucher
Fabry
Disease Information
Management of Fabry Disease
Medical Information Services
Fabry Registry
Practical Info
Request Materials
MPS I
Pompe

 



 

Fabry Disease – Cerebrovascular Complications

Literature has documented that strokes and transient ischemic attacks are associated with Fabry disease. [1, 2] Thrombosis of small arteries thickened by the vascular accumulation of GL-3 lipids makes Fabry patients vulnerable to early ischemic stroke.[3] Thrombus formation may also be enhanced in Fabry disease due to adhesion of neutrophils and monocytes to endothelial cell walls.[4] Hypertension associated with renal dysfunction may also increase the risk for hemorrhagic stroke.[3]

Other Fabry-related cerebrovascular signs and symptoms associated with Fabry disease may include:[1]

Hemiparesis
Vertigo
Diplopia
Seizures
Basilar artery ischema and aneurism
Labyrinthine disorders
Cerebral hemorrhage

References
1. Desnick RJ, Ioannou YA, Eng CM. Alpha-galactosidase A deficiency: Fabry disease. In: The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw Hill, 2001;3733-3774.

2. Grewal RP. Stroke in Fabry's disease. J Neurol 1994;241:153-156.

3. Grewal RP, McLatchey SK. Cerebrovascular manifestations in a female carrier of Fabry's disease. Acta Neurol Belg. 1992;92:36-40.

4. DeGraba T, Azhar S, Dignat-George F, et al. Profile of endothelial and leukocyte activation in Fabry patients. Ann Neurol. 2000;47:229-233.

 
Print

PRINT

Bookmark

BOOKMARK




01/01/2007: Low bone density in Gaucher disease improves with CerezymeŽ

01/05/2007: Treatment for Pompe disease now available for Belgian patients

01/03/2006: Early treatment with FabrazymeŽ significantly slows progression of Fabry

More >



Lysosomal Storage Disorders
General information
Gaucher Disease
Fabry Disease
MPS I Disease
Pompe Disease